Overview

Amonafide in Combination With Cytarabine in Secondary AML

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This protocol is designed to assess the safety and efficacy of amonafide in combination with cytarabine in subjects with previously untreated secondary AML.
Phase:
Phase 2
Details
Lead Sponsor:
Xanthus Pharmaceuticals, Inc.
Treatments:
Amonafide
Cytarabine